Researchers at BioAegis in New Jersey have been studying a therapy for pneumonia patients that they say can help treat people with severe cases of COVID-19. It's a protein called gelsolin. Now they're trying to get it through the FDA approval process. Carol MacKenzie spoke with the Chief Medical Officer at BioAegis Therapeutics, Dr. Mark DiNubile, to find out what he's working on and why he thinks it can help COVID-19 patients.
See omnystudio.com/policies/listener for privacy information.
Learn more about your ad choices. Visit podcastchoices.com/adchoices